Valuation : CellSource Co., Ltd.

Market Cap 6.53B 42.53M 36.59M 34.46M 31.39M 58.74M 4.05B 58.97M 408M 158M 2.06B 160M 156M P/E 2026 *
110x
P/E 2027 * 59.8x
Enterprise Value 6.53B 42.53M 36.59M 34.46M 31.39M 58.74M 4.05B 58.97M 408M 158M 2.06B 160M 156M EV / Sales 2026 *
1.81x
EV / Sales 2027 * 1.72x
Free-Float
45.74%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week-4.99%
Current month-9.24%
1 month-1.82%
3 months+2.86%
6 months-15.62%
Current year-18.80%
1 week 321
Extreme 321
366
1 month 318
Extreme 318
366
Current year 294
Extreme 294
442
1 year 294
Extreme 294
635
3 years 294
Extreme 294
2,600
5 years 294
Extreme 294
8,160
10 years 294
Extreme 294
8,160
Manager TitleAgeSince
Chief Executive Officer 62 2025-10-31
Director of Finance/CFO - 2025-12-31
Corporate Officer/Principal - 2023-12-31
Director TitleAgeSince
Director/Board Member 64 2017-05-31
Chairman 62 2024-01-24
Director/Board Member 57 2022-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-4.99%-47.06%-86.87% 42.53M
-0.33%-5.21%+45.12%-2.77% 80.65B
-1.00%-3.42%-19.64%-36.89% 59.12B
-3.36%-10.08%+454.19%+25.98% 54.14B
+0.83%-3.26%-9.28%+30.44% 50.1B
-1.22%-8.07%-2.64%+146.18% 45.33B
-0.83%-5.36%+46.75%-18.63% 31.14B
+1.29%-2.19%+47.21%+96.95% 25.54B
-3.92%-8.04%-5.27%+146.34% 21.8B
-0.32%-3.74%+64.37%+99.64% 16.06B
Average -0.46%-3.82%+57.37%+40.04% 38.39B
Weighted average by Cap. -0.16%-3.85%+78.30%+36.04%

Financials

2026 *2027 *
Net sales 3.6B 23.44M 20.17M 18.99M 17.31M 32.38M 2.23B 32.51M 225M 87M 1.14B 88.02M 86.11M 3.8B 24.74M 21.29M 20.05M 18.27M 34.18M 2.35B 34.31M 238M 91.83M 1.2B 92.91M 90.89M
Net income 60M 391K 336K 317K 288K 540K 37.18M 542K 3.75M 1.45M 18.94M 1.47M 1.44M 110M 716K 616K 580K 529K 989K 68.16M 993K 6.88M 2.66M 34.72M 2.69M 2.63M
Net Debt - -
Logo CellSource Co., Ltd.
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
Employees
148
Date Price Change Volume
26-09-10 JP¥324.00 -1.52% 81,600
26-09-09 JP¥329.00 -1.50% 469,200
26-09-08 JP¥334.00 -2.62% 93,600
26-09-07 JP¥343.00 -0.87% 27,400
26-09-04 JP¥346.00 +1.47% 26,100
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4880 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!